Back to Agenda
ON DEMAND - Impact Patient-Centered Initiatives in Clinical Trial Design and Execution
Session Chair(s)
Mary Elmer, BSN, MSN, RN
Executive Director, Patient Engagement for Oncology, Merck & Co., Inc., United States
The Patient Experience Initiative developed tools to provide more effective ways to engage with patients in design and execution of clinical studies. These tools will be presented and their impact will be discussed.
Learning Objective : Discuss patient perspectives on clinical trial access, design, conduct and post-trial follow-up, based on recent forums and collaborations; Describe publicly available tools for engaging patients in study design and measuring experiences during clinical trials; Describe how gathering patient feedback during protocol development and from clinical study patients during the study may help improve patient experience and reduce patient burden.
Speaker(s)
A Stage IV Cancer Patient's Perspective on Clinical Trials
Writer and Speaker, Patient Advocate, Independent Consultant, United States
Putting Patients at the Heart of Clinical Research: New Learnings, Solutions, and Best Practices
Chief Scientific Officer, Medable, United States
Multi-Stakeholder Approach to Incorporating the Patient Voice into Medicines Development
Enterprise Clinical Trial Data Sharing Lead, Global Data Dissemination, Pfizer Inc, United States
Patient Focused Drug Development: Considerations for Clinical Trial Design and Execution
Director, Patient Focused Drug Development, OCD, CDER, FDA, United States
Have an account?